Wichtige endokrine Funktionsstörungen bei Schwangeren

 

 Permissions and Reprints

Zusammenfassung

Endokrine Störungen haben einen bedeutsamen Einfluss auf die Fertilität, den Verlauf einer Schwangerschaft und die fetale Entwicklung. So ist die Fertilität bei Patientinnen mit Autoimmunerkrankungen, z. B. M. Addison oder der Autoimmunthyreoiditis, eingeschränkt und das Fehlgeburtsrisiko erhöht. Die Behandlung einer endokrinen Störung muss während einer Schwangerschaft häufig angepaßt werden. So muss bei Patientinnen mit einem M. Addison die erforderliche Substitutionsdosis von Hydrocortison erhöht werden. Dies gilt auch für die Entbindung. Von besonderer klinischer Bedeutung sind die Erkrankungen der Schilddrüse. Eine Hypothyreose muß in der Frühschwangerschaft rasch mit Levothyroxin ausgeglichen werden. Eine Jodsupplementierung wird nachhaltig während der Schwangerschaft und der Stillperiode empfohlen. Eine Autoimmunhyperthyreose wird im ersten Trimenon mit Propyluracil, danach mit Methimazol (Thiamazol) behandelt. Bei der durch hCG bedingten Gestationshyperthyreose verbietet sich hingegen eine Thyreostatikatherapie. Die Übersicht beschränkt sich auf die wichtigsten endokrinen Störungen in der Schwangerschaft.

Abstract

Endocrine disorders may have an important influence on fertility, the course of a pregnancy and fetal development. For example, fertility is decreased and the risk of miscarriage is increased in women with autoimmune disorders, such as Addison’s disease or autoimmune thyroiditis. Treatment of endocrine diseases in many cases has to be adapted during the course of a pregnancy. In patients with Addison’s disease the dosage of hydrocortisone necessarily has to be increased. This is also valid for the time of delivery. Disorders of the thyroid gland are of great importance during pregnancy. If hypothyroidism is diagnosed in early pregnancy, immediate treatment with levothyroxine should be initiated. Iodine supplementation is strongly recommended in all pregnant and breast-feeding women. Treatment of Graves’s disease will be performed during the first trimenon with propylthiouracile, afterwards with methimazole (thiamazole). In contrast, thyrotoxicosis due to hCG should not be treated with methimazole. In this paper, we present an overview on the most important endocrine disorders during pregnancy.

• Literatur

• 1 Führer D. Schilddrüsenerkrankungen und Schwangerschaft. Der Internist 2011; 52: 1158-1166
  CrossrefPubMedGoogle Scholar
• 2 Poppe K, Velkeniers B, Glinoer D. The role of autoimmunity in fertility and pregnancy. Nat clin prac Endocr Metab 2008; 4: 394-405
  PubMedGoogle Scholar
• 3 Janssen OE, Mehlmauer N, Hahn S et al. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol 2004; 150: 363-369
  CrossrefPubMedGoogle Scholar
• 4 Thanagartian S, Tan A, Knox E at al. Association between thyroid autoantibodies and misscariage and preterm birth: meta-analysis of evidence. BMI 2011; 342: 2616-2624
  PubMedGoogle Scholar
• 5 Bullmann MinnemannC, Schilddrüse T. Fertilität und Schwangerschaft. Der Gynäkologe 2015; 48: 537-546
  CrossrefPubMedGoogle Scholar
• 6 Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaption from physiology to pathology. Endocr Rev 1997; 14: 194-202
  PubMedGoogle Scholar
• 7 Wasserstrum N, Anania CA. Prenatal consequences of maternal hypothyroidism in early pregnancy and inadequate replacement. Clin Endocrinol 1995; 42: 353-358
  CrossrefPubMedGoogle Scholar
• 8 Stagnaro-Green A, Pearce E. Thyroid disorders in pregnancy. Nature Reviews Endocrinology 2012; 8: 650-658
  CrossrefPubMedGoogle Scholar
• 9 Stoffaneller R, Morse NL. A review of diatary selenium intake and selenium status in Europe and the middle East. Nutrience 2015; 7: 1494-1537
  PubMedGoogle Scholar
• 10 Wu Q, Rayman MP, Lv H et al. Low population selenium status is associated with increased prevalence of thyroid disease. J Clin Endocrinol Metab 2015; 100: 4037-4047
  CrossrefPubMedGoogle Scholar
• 11 Negro R, Greco G, Mangieri T et al. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. JCEM 2007; 92: 1263-1268
  PubMedGoogle Scholar
• 12 Marcocci C, Kahaly GL, Krassas GE et al. Selenium and the course of mild Graves orbitopathy. New Engl J Med 2011; 364: 1920-1931
  CrossrefPubMedGoogle Scholar
• 13 Bartalena L, Baldeschi L, Boboridis K et al. The 2016 European Thyroid Association / European group on Graves’ orbitopathy guideline fort he managemenet of Graves’orbitopathy. Europ Thyroid J 2016; 5: 9-26
  PubMedGoogle Scholar
• 14 Azizi F, Amouzegar A. Management of hyperthyroidism during pregnancy and lactation. Europ J Endocrinol 2011; 164: 871-876
  CrossrefPubMedGoogle Scholar
• 15 Abalovich M, Amino N, Barbour LA et al. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2007; 92: S1-S47
  CrossrefPubMedGoogle Scholar
• 16 Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010; 31: 702-755
  CrossrefPubMedGoogle Scholar
• 17 Perres-Lobato R, Ramos R, Arrebola JP, Calvente I et al. Thyroid status and its association with cognitive functioning in healthy boys at 10 years of age. Eur J Endocrinol 2015; 172: 129-139
  PubMedGoogle Scholar
• 18 Führer D, Mann K, Feldkamp J et al. Schilddrüsendysfunktion in der Schwangerschaft. Dtsch Med Wschr 2014; 139: 2148-2152
  Article in Thieme ConnectPubMedGoogle Scholar
• 19 Maraka S, Ospina NM, O‘Keeffe DT. Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis. Thyroid 2016; 26: 580-590
  CrossrefPubMedGoogle Scholar
• 20 Korevaar TI, Muetzel R, Medici M et al. Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study. Lancet Diabetes Endocrinol 2016; 4: 35-43
  Google Scholar
• 21 Haddow JE, Palomaki GE, Allan WC et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development oft he child. N Engl J Med 1999; 341: 549-855
  CrossrefPubMedGoogle Scholar
• 22 Lazarus J, Brown RS, Daumerie C et al. 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J 2014; 3: 76-94
  CrossrefPubMedGoogle Scholar
• 23 Ghassabian A, Bongers-Schokking JJ, de Rijke YB et al. Maternal thyroid autoimmunity during pregnancy and the risk of attention deficit / hyperactivity problems in children: the Generation R Study. Thyroid 2012; 22: 178-186
  CrossrefPubMedGoogle Scholar
• 24 Pulzer A, Burger-Stritt S, Hahner S. Morbus Addison Der Internist 2016; 5: 457-467
  PubMed
• 25 Stagnaro-Green A, Abalovich M, Alexander E et al. Guidelines of the American thyroid association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011; 21: 1081-1116
  CrossrefPubMedGoogle Scholar
• 26 Feldkamp J, Führer D, Luster M, Musholt T J, Spitzweg C, Schott M. Feinnadelpunktion in der Abklärung von Schilddrüsenknoten. Deutsches Ärzteblatt 2016; 113: 353-359
  PubMedGoogle Scholar
• 27 Bornstein SR, Allolio B, Arlt W et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101: 364-381
  CrossrefPubMedGoogle Scholar
• 28 Lebbe M, Arlt W. What ist the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy?. Clin Endocrinol 2013; 78: 497-502
  CrossrefPubMedGoogle Scholar
• 29 Erichsen MM, Husebye ES, Michelsen TM et al. Sexuality and fertility in women with Addison’s disease. J. Clin. Endocrinol. Metab 2010; 95: 4354-43607
  CrossrefPubMedGoogle Scholar
• 30 Jung C, Ho JT, Torpy TJ et al. A longitudinal study of plasma and urinary cortisol in pregnancy and post partum. J Clin Endocrinol Metab 2011; 96: 1533-1540
  CrossrefPubMedGoogle Scholar
• 31 Remde H, Zopf K, Schwander J, Quinkler M. Fertility and pregnancy in primary adrenal insufficiency in Germany. Horm Metab Res 2016; 48: 306-311
  Article in Thieme ConnectPubMedGoogle Scholar
• 32 Miliku K, Vinkhuyzen A, Blanken LM et al. Maternal vitamin D concentrations during pregnancy, fetal growth patterns, and risks of adverse birth outcomes. Amer J Clin Nutr 2016; DOI: pii: ajcn 123 752.
  PubMedGoogle Scholar
• 33 Palacios C, De-Regil LM, Lombardo LK, Pena-Rosas JP. Vitamin D supplementation during pregnancy: updated meta-analysis on maternal outcomes. J. Steroid. Biochem Mol Biol 2016; DOI: 10.1016/j.jsbmb.2016.02.008.
  PubMedGoogle Scholar
• 34 De-Regil LM, Palacios C, Lombardo LK, Pena-Rosas JP. Vitamin D Supplementation for women during pregnancy. Cochrane Database Syst Rev 2016; 14 DOI: 10.1002/14651858.CD008873.
  PubMedGoogle Scholar